Call for Abstract
31st Experts Meet on Cancer Therapy and Immuno Oncology, will be organized around the theme “Challenges for Oncology Research and Cancer treatment during the COVID-19 pandemic”
Cancer Therapy Meeting 2020 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Cancer Therapy Meeting 2020
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 1-1Induced pluripotent stem cells
- Track 1-2Stem Cell Transplantation
- Track 1-3Hematopoietic Stem cell therapy
- To help diagnose conditions, as in the case of identifying early stage cancers
- To figure how forceful a condition is, as on account of deciding a patient's capacity to admission without treatment
- Track 2-1Imaging biomarkers
- Track 2-2Sponge biomarkers
- Track 2-3Protein phosphorylation biomarkers
- Track 3-1Cancer genomics
- Track 3-2Cancer Therapy
Diagnostics assumes a key job all through every patient's malignant growth venture—previously, during and after treatment. During treatment, we track the size of the tumor, the infection's movement and your reaction to treatment, and adjust your treatment as required. In specific situations, insignificantly obtrusive apparatuses like navigational bronchoscopy and endoscopic ultrasound enable us to find and arrive at extremely little tumors without the requirement for medical procedure. After treatment, we help you avert, distinguish and deal with the reactions of the illness and its treatment, and we plan normal registration to screen for indications of metastasis or repeat.
- Track 4-1Clinical Diagnosis
- Track 4-2Mammography
- Track 4-3Nuclear imaging
- Track 4-4Sigmoidoscopy
The most widely used treatments for cancer are surgery, radiotherapy and chemotherapy. Chemotherapy is the main choice for metastatic malignant growths, where the treatment must be foundational. The most often utilized chemotherapy medications have been distinguished experimentally with no previous information in regards to the sub-atomic instrument of activity of the medications. In spite of the noteworthy advancement accomplished in malignant growth care and research in the course of recent decades, the treatment alternatives for most of epithelial tumors have not changed a lot. In any case, a minimum amount of information has been collected that may change malignant growth medicines from cytotoxic regimens towards the quickly separating cells into customized focused on treatments. This section will give a review of as of now utilized chemotherapeutics and will investigate the effect of the atomic comprehension of malignancy on present day tranquilize disclosure, medicate improvement and disease treatment.
- Track 5-1Cancer drugs
- Track 5-2Radiotherapy
- Track 5-3Chemotherapy
Radiation therapy uses waves of energy, such as light or heat, to treat cancers and other tumors and conditions. The form of radiation used in cancer therapy is a high-energy type known as ionizing radiation.Scientists still do not know exactly how radiation works as a treatment for cancer.They do know, however, that it breaks up the DNA of cancer cells in a way that disrupts their growth and division. In this way, radiation can kill cancer cells, preventing or slowing the spread of the disease.Sometimes a doctor prescribes radiation therapy alone, but usually, they recommend it in combination with other treatments, such as chemotherapy, surgery or both.
- Track 6-1Stereotactic radiosurgery
- Track 6-2Image-guided radiation therapy
- Track 6-3Intraoperative radiation therapy
- Track 6-43D conformal radiation therapy
Malignant growth immunotherapy is the fake incitement of the safe framework to treat malignant growth, enhancing the invulnerable framework's regular capacity to battle the malady. It is a use of the basic research of malignant growth immunology and a developing subspeciality of oncology. It abuses the way that malignancy cells frequently have tumor antigens, atoms on their surface that can be recognized by the immunizer proteins of the resistant framework, official to them. The tumor antigens are frequently proteins or different macromolecules. Typical antibodies tie to outside pathogens, however the altered immunotherapy antibodies tie to the tumor antigens stamping and recognizing the malignant growth cells for the safe framework to restrain or execute.
- Track 7-1Clinical Cancer immunology
- Track 7-2Cellular Immunotherapy
- Track 7-3Antibody Therapy
- Track 7-4Cancer Antigens & Vaccines
- Track 8-1Ductal Carcinoma In Situ
- Track 8-2Triple Negative Breast Cancer
- Track 8-3Invasive Ductal Carcinoma
Lung disease, otherwise called lung carcinoma, is a threatening lung tumor portrayed by uncontrolled cell development in tissues of the lung This development can spread past the lung by the methodology of metastasis into near to tissue or various bits of the body. Most malignancies that start in the lung, known as essential lung diseases, are carcinomas. The two fundamental sorts are little cell lung carcinoma and non-little cell lung carcinoma. The most common symptoms are coughing, weight loss, shortness of breath, and chest pains.
- Track 9-1Adenocarcinoma
- Track 9-2Squamous Cell Carcinoma
- Track 9-3Carcomatoid Carcinoma
- Track 9-4Lung Carcinoid Tumors
- Track 9-5Small Cell Lung Cancer Staging
Gastrointestinal illness implies perilous conditions of the gastrointestinal tract and decoration organs of preparing, including the throat, stomach, biliary structure, pancreas, little stomach related tract, interior organ, rectum and butt.The indications identify with the organ influenced and can incorporate hindrance, strange draining or other related issues. The conclusion regularly requires endoscopy, trailed by biopsy of suspicious tissue. The treatment relies upon the area of the tumor, just as the kind of malignant growth cell and whether it has attacked different tissues or spread somewhere else. These variables likewise decide the visualization.
- Track 10-1Anal cancer
- Track 10-2Bile duct cancer
- Track 10-3Biliary cancer
- Track 10-4Gastrointestinal carcinoid tumor
Gynecologic oncology is a specific field of medication that spotlights on malignant growths of the female conceptive framework, including ovarian disease, uterine disease, vaginal malignant growth, cervical malignancy, and vulvar disease. As authorities, they have broad preparing in the determination and treatment of these malignant growths.
- Track 11-1Cervical Cancer
- Track 11-2Endometrial Cancer
- Track 11-3Ovarian Cancer
- Track 11-4Uterine Cancer
- Track 11-5Vulvar Cancer
Hematology, additionally spelled hematology, is the part of medication worried about the investigation of the reason, visualization, treatment, and avoidance of infections identified with blood. It includes treating infections that influence the generation of blood and its segments, for example, platelets, hemoglobin, blood proteins, bone marrow, platelets, veins, spleen, and the system of coagulation. Such illnesses may incorporate hemophilia, blood clumps, other draining issue and blood malignant growths, for example, leukemia, numerous myeloma, and lymphoma. The research facility work that goes into the investigation of blood is habitually performed by a restorative technologist or medicinal lab researcher.Haematological malignancies are the types of cancer affecting blood, bone marrow and lymph nodes. They are referred to as leukaemia, lymphoma and myeloma depending on the type of cell affected.
- Track 12-1Myeloma
- Track 12-2Lymphoma
- Track 12-3Leukaemia
- Track 12-4Acute myeloid leukemia
Skin malignant growths are diseases that emerge from the skin. They are because of the advancement of strange cells that can attack or spread to different pieces of the body. There are three main types of skin cancers: basal-cell skin cancer, squamous-cell skin cancer and melanoma. The initial two, alongside various less regular skin malignant growths, are known as nonmelanoma skin disease. Basal-cell disease develops gradually and can harm the tissue around it however is probably not going to spread to far off territories or result in death. It frequently shows up as an effortless raised territory of skin, that might be gleaming with little veins running over it or may present as a raised region with a ulcer. Squamous-cell skin disease is bound to spread. It normally shows as a hard irregularity with a layered top however may likewise shape a ulcer. Melanomas are the most forceful. Signs incorporate a mole that has changed in size, shape, shading, has unpredictable edges, has more than one shading, is bothersome or drains.
- Track 13-1Basal cell carcinoma
- Track 13-2Squamous Cell Carcinoma
- Track 13-3Melanoma
Head and neck malignancy is a gathering of diseases that starts in the mouth, nose, throat, larynx, sinuses, or salivary organs. Side effects for head and neck malignant growth may incorporate an irregularity or sore that doesn't mend, an irritated throat that doesn't leave, inconvenience gulping, or an adjustment in the voice. Not utilizing tobacco or liquor can decrease the take an enormous risk disease. While screening in the overall public doesn't seem, by all accounts, to be helpful, screening high hazard bunches by assessment of the throat may be valuable. Head and neck cancer often is curable if it is diagnosed early however, outcomes are typically poor if it is diagnosed late.Treatment may include a combination of surgery, radiation therapy, chemotherapy, and targeted therapy.
- Track 14-1Laryngeal Cancer
- Track 14-2Paranasal sinus cancer
- Track 14-3Hypopharyngeal cancer
- Track 14-4Salivary gland cancer
Pediatric oncology is the examination and treatment of tumors in youngsters and youthful grown-ups. Pediatric oncologists study and train in both pediatrics and oncology. The types of cancers that develop in children are often different from cancers that develop in adults.Pediatric oncology is the branch of medicine concerned with the diagnosis and treatment of cancer in children.
- Track 15-1Osteosarcoma
- Track 15-2Hepatoblastoma
- Track 15-3Neuroblastoma
- Track 15-4Retinoblastoma
- Track 16-1Tumor Metastasis
- Track 16-2Peritoneum Metastasis
Pancreatic malignancy emerges when cells in the pancreas, a glandular organ behind the stomach, start to duplicate wild and structure a mass. These cancerous cells have the ability to invade other parts of the body. There are various sorts of pancreatic disease. The most widely recognized, pancreatic adenocarcinoma, represents about 85% of cases, and the expression "pancreatic malignant growth" is in some cases used to allude just to that type. These adenocarcinomas start inside the piece of the pancreas which makes stomach related proteins. A few different kinds of disease, which all in all speak to most of the non-adenocarcinomas, can likewise emerge from these cells. One to two percent of cases of pancreatic cancer are neuroendocrine tumors, which arise from the hormone-producing cells of the pancreas. These are generally less aggressive than pancreatic adenocarcinoma.
- Track 17-1Exocrine tumors
- Track 17-2Pancreatic neuroendocrine tumors
Tumor microenvironment is the earth around a tumor, including the joining veins, safe cells, fibroblasts, hailing particles and the extracellular framework. The tumor and the encompassing microenvironment are firmly related and interface continually. Tumors can impact the microenvironment by discharging extracellular sign, advancing tumor angiogenesis and inciting fringe insusceptible resistance, while the safe cells in the microenvironment can influence the development and advancement of malignant cells
- Track 18-1Cancer-associated fibroblasts
- Track 18-2Myeloid-derived suppressor cells
Adoptive T-Cell Therapy for Solid Tumors Chimeric antigen receptor (CAR) T-cell therapy is an innovative form of immunotherapy wherein autologous T cells are genetically modified to express chimeric receptors encoding an antigen-explicit single-chain variable piece and different costimulatory atoms. Chimeric antigen receptor T-cell therapy is an innovative form of immunotherapy wherein autologous T cells are genetically modified to express chimeric receptors encoding an antigen-specific single-chain variable fragment and various costimulatory molecules. Upon organization, these adjusted T cells traffic to, and perceive, malignant growth cells in a HLA-autonomous way.
- Track 19-1Adoptive T-cell Therapy
- Track 19-2Tumor cell Therapy
- Track 19-3Solid Tumor Cell Therapy
Oral cavity and oropharyngeal carcinomas represents a significant cause of morbidity and mortality. In spite of endeavors in improving early finding and treatment, the 5-year endurance pace of cutting edge phase of the illness is under 63%.The field of nanomedicine has offered promising diagnostic and therapeutic advances in cancer. Without a doubt, a few stages have been clinically affirmed for disease treatment, while other promising frameworks are experiencing investigation in clinical preliminaries.With its ability to deliver drugs, nucleic acids, and MRI contrast agents with high efficiency, nanomedicine platforms offer the potential to improve drug efficacy and tolerability. The point of the present smaller than expected audit is to abridge the current preclinical status of nanotechnology frameworks for oral malignant growth treatment.
- Track 20-1Cancer Nanotechnology
- Track 20-2Cancer Pharmocology
The investigation of the tumor digestion, otherwise called tumor metabolome depicts the distinctive trademark metabolic changes in tumor cells. The characteristic attributes of the tumor metabolome are high glycolytic enzyme activities, the expression of the pyruvate kinase isoenzyme type M2, increased channeling of glucose carbons into synthetic processes, for example, nucleic corrosive, amino corrosive and phospholipid blend, a high pace of pyrimidine and purine again union, a low proportion of Adenosine triphosphate and Guanosine triphosphate to Cytidine triphosphate and Uridine triphosphate, low Adenosine monophosphate levels, high glutaminolytic limits, arrival of immunosuppressive substances and reliance on methionine.
- Track 21-1Neoplasm
- Track 21-2Tumor Cell Metabolite
Immuno oncology is the fake incitement of the invulnerable framework to treat malignant growth, enhancing the resistant framework's normal capacity to battle the illness.It is an utilization of the crucial research of disease immunology and a developing subspeciality of oncology. It abuses the way that malignant growth cells regularly have tumor antigens, atoms on their surface that can be identified by the immunizer proteins of the insusceptible framework, official to them. The tumor antigens are often proteins or other macromolecules.Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill. In 2018, James P. Allison and Tasuku Honjo got the Nobel Prize in Physiology or Medicine for their revelation of malignancy treatment by hindrance of negative invulnerable guideline.
- Track 22-1Monoclonal antibodies and tumor-agnostic therapies